html { overflow: visible; height: auto; } .MainNav_ItemWrapper:hover .Subnavigation_Wrapper, .MainNav_Item:focus + .Subnavigation_Wrapper { display: block; } .Header-FixedHeight .Dialoog, .Header-FixedHeight .Title_Wrapper, .Accordion_ContentContainer.Hidden { height: auto !important; visibility: visible; } .Dialoog_Step.Invisible, .Title_Wrapper.Invisible, main.Invisible, .js-GridItem { transform: none; opacity: 1; } .Dialoog_Form, .js-OptionsOpenBtn, .Image_Wrapper-Scaled, .Video_Wrapper-Scaled, img[data-src] { display: none; } .js-MasonryGrid { display: flex; flex-wrap: wrap; }

ATTRACT 2025

6 European anti-cancer charities join forces and launch the ATTRACT 2025 call to stimulate international research on the treatment of rare cancers. We are pioneering with this partnership to tackle the funding gap for international research projects, especially in the field of rare cancer therapeutics. Our ambitious aim is to improve the treatment of rare cancers by helping new drug innovations from research into clinical practice, making the best possible treatments accessible to rare cancer patients everywhere.

More information can be found on this foundation-arc.org page.